Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rosiglitazone Hydrochloride Tablets

Approval Number

国药准字H20080258

Company浙江海正药业股份有限公司

Registration Date

November 14, 2022

Previous Approval Numbers

国药准字H20080258

Drug Information

Generic Name

盐酸罗格列酮片

Dosage Form

片剂

Strength

以C18H19N3O3S计 8mg

Drug Type

化学药品

Registration Date

November 14, 2022

Company Information

Applicant Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区外沙路46号

Manufacturing Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省台州市椒江区海正大道1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy